AAAAAA

   
Results: 1-15 |
Results: 15

Authors: BARRETT PN MEYER H WACHTEL I EIBL J DORNER F
Citation: Pn. Barrett et al., INACTIVATION OF HEPATITIS-A VIRUS IN PLASMA PRODUCTS BY VAPOR HEATING, Transfusion, 37(2), 1997, pp. 215-220

Authors: FISCHER BE MITTERER A SCHLOKAT U GRILLBERGER L REITER M MUNDT W DORNER F EIBL J
Citation: Be. Fischer et al., IMMOBILIZED HIRUDIN AND HIRUDIN-BASED PEPTIDES USED FOR THE PURIFICATION OF RECOMBINANT HUMAN THROMBIN PREPARED FROM RECOMBINANT HUMAN PROTHROMBIN, Protein expression and purification, 8(2), 1996, pp. 167-174

Authors: EIBL J BARRETT N HAMMERLE T DORNER F
Citation: J. Eibl et al., NANOFILTRATION OF IMMUNOGLOBULIN WITH 35-NM FILTERS FAILS TO REMOVE SUBSTANTIAL AMOUNTS OF HCV, Biologicals, 24(3), 1996, pp. 285-287

Authors: FISCHER BE SCHLOKAT U MITTERER A GRILLBERGER L REITER M MUNDT W DORNER F EIBL J
Citation: Be. Fischer et al., DIFFERENTIATION BETWEEN PROTEOLYTIC ACTIVATION AND AUTOCATALYTIC CONVERSION OF HUMAN PROTHROMBIN - ACTIVATION OF RECOMBINANT HUMAN PROTHROMBIN AND RECOMBINANT D419N-PROTHROMBIN BY SNAKE-VENOMS FROM ECHIS-CARINATUS AND OXYURANUS-SCUTELLATUS, Protein engineering, 9(10), 1996, pp. 921-926

Authors: BARRETT PN MEYER H WACHTEL I EIBL J DORNER F
Citation: Pn. Barrett et al., DETERMINATION OF THE INACTIVATION KINETICS OF HEPATITIS-A VIRUS IN HUMAN PLASMA PRODUCTS USING A SIMPLE TCID50 ASSAY, Journal of medical virology, 49(1), 1996, pp. 1-6

Authors: FISCHER BE KRAMER G MITTERER A GRILLBERGER L REITER M MUNDT W DORNER F EIBL J
Citation: Be. Fischer et al., EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON-WILLEBRAND-FACTOR ON PLATELET-AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION-FACTOR-VIII, Thrombosis research, 84(1), 1996, pp. 55-66

Authors: FISCHER BE SCHLOKAT U MITTERER A SAVIDISDACHO H GRILLBERGER L REITER M MUNDT W DORNER F EIBL J
Citation: Be. Fischer et al., RATIONAL DESIGN, RECOMBINANT PREPARATION, AND IN-VITRO AND IN-VIVO CHARACTERIZATION OF HUMAN PROTHROMBIN-DERIVED HIRUDIN ANTAGONISTS, The Journal of biological chemistry, 271(39), 1996, pp. 23737-23742

Authors: BARRETT N POLSLER G EIBL J DORNER F
Citation: N. Barrett et al., VALIDATION OF VIRUS INACTIVATION REMOVAL PROCEDURES USED IN THE MANUFACTURE OF HUMAN BLOOD PRODUCTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1022-1022

Authors: EIBL J CUPPERS HH
Citation: J. Eibl et Hh. Cuppers, INHERENTLY SAFE CONTAINMENTS FOR NUCLEAR-POWER-PLANTS, Nuclear Engineering and Design, 154(2), 1995, pp. 203-209

Authors: KESSLER G EIBL J
Citation: G. Kessler et J. Eibl, SEVERE ACCIDENT CONTAINMENT LOADS AND POSSIBLE DESIGN CONCEPTS OF FUTURE LARGE PRESSURIZED-WATER REACTORS, Nuclear technology, 111(3), 1995, pp. 358-368

Authors: BUTSCH J SCHLUTER FH EIBL J
Citation: J. Butsch et al., FEASIBILITY STUDY FOR A CONTAINMENT TO RESIST CORE-MELT ACCIDENTS, Nuclear technology, 111(3), 1995, pp. 426-436

Authors: SCHWARZ HP KUNSCHAK M ENGL W EIBL J
Citation: Hp. Schwarz et al., HIGH-PURITY FACTOR CONCENTRATES IN PREVENTION OF AIDS, Lancet, 343(8895), 1994, pp. 478-479

Authors: EIBL J KOBLER G
Citation: J. Eibl et G. Kobler, IMPACT RESEARCH FOR CONTAINMENT DESIGN, Nuclear Engineering and Design, 150(2-3), 1994, pp. 409-415

Authors: EIBL J KOBLER G
Citation: J. Eibl et G. Kobler, IMPACT RESEARCH FOR CONTAINMENT DESIGN, Nuclear Engineering and Design, 150(2-3), 1994, pp. 409-415

Authors: HOCHST S LEUCKEL W EIBL J
Citation: S. Hochst et al., EXPERIMENTAL STUDIES ON THE COURSE OF DUS T EXPLOSIONS IN A PRESSURE RELEASE EXPERIMENTAL SILO CELL, Chemieingenieurtechnik, 65(12), 1993, pp. 1488-1490
Risultati: 1-15 |